Respiratory Devices and Equipment (Diagnostic) Market Outlook 2025-2034: Market Share, and Growth Analysis

The Respiratory Devices and Equipment (Diagnostic) Market is valued at USD 10.4 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 19.3 billion by 2034.

The Respiratory Devices and Equipment (Diagnostic) Market plays a crucial role in identifying, monitoring, and managing a wide range of respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and acute respiratory infections. Diagnostic respiratory equipment includes spirometers, peak flow meters, pulse oximeters, capnographs, and polysomnography devices, which are commonly used in clinical settings, outpatient centers, and increasingly in home care environments. Rising incidences of respiratory illnesses - driven by pollution, smoking, aging populations, and post-COVID-19 complications - have heightened the need for early diagnosis and respiratory health monitoring. In addition, growing awareness of preventive healthcare and the adoption of portable and digital diagnostic tools have expanded access to respiratory assessments. Healthcare systems are investing in advanced diagnostic solutions for better patient outcomes, reduced hospital admissions, and more efficient disease management, particularly in chronic and lifestyle-related respiratory conditions.

The respiratory diagnostic devices market saw solid growth, spurred by increased demand for non-invasive, portable tools that enable remote and early-stage disease monitoring. Pulmonary function testing saw wider deployment in primary care and telehealth settings, with spirometry systems becoming more compact and user-friendly. Healthcare providers also incorporated advanced pulse oximetry and capnography into routine respiratory assessments, particularly in sleep clinics and post-acute care. Diagnostic manufacturers introduced connected devices capable of integrating with electronic health records (EHR) and telemedicine platforms, improving data sharing and physician-patient collaboration. Increased investment in respiratory screening programs, particularly in Asia-Pacific and Latin America, addressed rising rates of undiagnosed asthma and COPD. Moreover, clinical research and regulatory updates accelerated innovation in AI-driven diagnostics, improving the interpretation of pulmonary function results and identifying at-risk patients more efficiently. Public and private partnerships emphasized population-wide screening and chronic disease surveillance to reduce long-term healthcare costs.

The respiratory diagnostic devices market is expected to evolve through greater integration with artificial intelligence, personalized medicine, and decentralized care models. AI-enhanced diagnostic platforms will offer predictive insights, enabling earlier interventions and tailored treatment plans. Mobile-enabled spirometers and wearable respiratory sensors will empower patients to monitor their conditions at home, reducing the burden on clinical infrastructure. Growth in home-based diagnostic testing will coincide with advances in cloud-based data analytics, allowing for seamless remote monitoring by healthcare professionals. In parallel, government policies supporting early diagnosis of chronic respiratory diseases will drive the expansion of screening initiatives in schools, workplaces, and rural areas. Technological innovation will also address diagnostic gaps in pediatric and geriatric populations, enhancing usability and sensitivity. However, affordability and access challenges in low-income regions may hinder widespread adoption unless supported by global health organizations and scalable manufacturing strategies focused on cost-effective solutions.

Key Insights: Respiratory Devices and Equipment (Diagnostic) Market

• Integration of AI and machine learning in diagnostic devices is improving interpretation accuracy and facilitating early detection of chronic respiratory conditions.
• Portable and smartphone-compatible spirometers are gaining popularity, enabling at-home monitoring and supporting telehealth consultations.
• Cloud-based data platforms are enhancing connectivity between patients and providers, offering real-time health insights and remote tracking.
• Multifunctional diagnostic devices combining spirometry, oximetry, and capnography are streamlining respiratory assessments in both clinical and home settings.
• Regulatory support and reimbursement models for remote patient monitoring are accelerating adoption of digital respiratory diagnostic tools.

• Rising prevalence of respiratory diseases such as COPD, asthma, and sleep apnea is increasing demand for diagnostic evaluations across demographics.
• Post-pandemic health awareness has led to higher investments in early-stage respiratory screening and monitoring infrastructure.
• Expansion of telehealth and remote care models is boosting the need for compact, user-friendly, and connected diagnostic solutions.
• Technological advancements in sensor miniaturization, data processing, and integration with electronic health records are improving diagnostic accuracy and efficiency.

• High costs of advanced diagnostic devices and lack of trained professionals in low-resource settings limit access to early respiratory disease detection and monitoring, especially in underserved regions.

Respiratory Devices and Equipment (Diagnostic) Market Segmentation

By Product

• Instruments and Devices
• Assays and Reagents

By Test Type

• Traditional Diagnostic Tests
• Mechanical Tests
• Imaging Tests
• Molecular Diagnostic Tests

By Disease Type

• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Asthma
• Tuberculosis
• Other Diseases

By End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Other End Users

Key Companies Analysed

• ResMed Inc.
• Medtronic plc
• Masimo Corporation
• Fisher & Paykel Healthcare Limited
• Koninklijke Philips N.V.
• Smiths Medical
• GE Healthcare
• Chart Industries Inc.
• Philips Healthcare
• Becton Dickinson and Company (BD)
• Abbott Laboratories
• Thermo Fisher Scientific Inc.
• Teleflex Incorporated
• Invacare Corporation
• Vyaire Medical Inc.
• Drägerwerk AG & Co. KGaA
• Getinge AB
• Dräger Medical GmbH
• bioMérieux
• Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc.
• Cosmed S.r.l.
• Seegene Inc.
• SDI Diagnostics
• GlaxoSmithKline plc
• Hillrom
• Hamilton Medical AG
• Medline Industries Inc.
• 3M Company
• Air Liquide
• Allied Healthcare Products Inc.
• Armstrong Medical
• Bio-Med Devices Inc.
• Breas Medical AB
• CAIRE Inc.
• DeVilbiss Healthcare
• Nihon Kohden Corporation
• O2 Concepts LLC

Respiratory Devices and Equipment (Diagnostic) Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Respiratory Devices and Equipment (Diagnostic) Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

• North America - Respiratory Devices and Equipment (Diagnostic) market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Respiratory Devices and Equipment (Diagnostic) market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • BeNeLux
  • Russia
  • Sweden
  
  
• Asia-Pacific - Respiratory Devices and Equipment (Diagnostic) market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Respiratory Devices and Equipment (Diagnostic) market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Respiratory Devices and Equipment (Diagnostic) market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru

Research Methodology

This study combines primary inputs from industry experts across the Respiratory Devices and Equipment (Diagnostic) value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

• What is the current and forecast market size of the Respiratory Devices and Equipment (Diagnostic) industry at global, regional, and country levels?
• Which types, applications, and technologies present the highest growth potential?
• How are supply chains adapting to geopolitical and economic shocks?
• What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
• Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
• Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
• Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?

Your Key Takeaways from the Respiratory Devices and Equipment (Diagnostic) Market Report

• Global Respiratory Devices and Equipment (Diagnostic) market size and growth projections (CAGR), 2024-2034
• Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Respiratory Devices and Equipment (Diagnostic) trade, costs, and supply chains
• Respiratory Devices and Equipment (Diagnostic) market size, share, and outlook across 5 regions and 27 countries, 2023-2034
• Respiratory Devices and Equipment (Diagnostic) market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
• Short- and long-term Respiratory Devices and Equipment (Diagnostic) market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, technological developments, and Respiratory Devices and Equipment (Diagnostic) supply chain analysis
• Respiratory Devices and Equipment (Diagnostic) trade analysis, Respiratory Devices and Equipment (Diagnostic) market price analysis, and Respiratory Devices and Equipment (Diagnostic) supply/demand dynamics
• Profiles of 5 leading companies - overview, key strategies, financials, and products
• Latest Respiratory Devices and Equipment (Diagnostic) market news and developments

Additional Support

With the purchase of this report, you will receive:

• An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
• Complimentary report update to incorporate the latest available data and the impact of recent market developments.

This product will be delivered within 1-3 business days.